| Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level : a modelling study | Lancet |  | | 2026 | 5 | 26 |
|
| Sample size calculations for pathogen variant surveillance in the presence of biological and systematic biases | Cell reports medicine | | | 2023 | 1 | 0 |
|
| Spatial distribution and determinants of childhood vaccination refusal in the United States | Vaccine | | | 2023 | 6 | 2 |
|
| Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022 : A multi-model study | The Lancet regional health. Americas | | | 2023 | 4 | 6 |
|
| Prioritizing interventions for cholera control in Kenya, 2015-2020 | PLoS neglected tropical diseases | | | 2023 | 1 | 3 |
|
| Spatial aggregation choice in the era of digital and administrative surveillance data | PLOS digital health | | | 2022 | 3 | 1 |
|
| The United States COVID-19 Forecast Hub dataset | Scientific data | | | 2022 | 5 | 8 |
|
| Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination | eLife | | | 2022 | 1 | 2 |
|
| Real-time COVID-19 forecasting : challenges and opportunities of model performance and translation | The Lancet. Digital health | | | 2022 | 1 | 9 |
|
| Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States | Proceedings of the National Academy of Sciences of the United States of America | | | 2022 | 4 | 4 |
|
| Effect of non-pharmaceutical interventions in the early phase of the COVID-19 epidemic in Saudi Arabia | PLOS global public health | | | 2022 | 3 | 6 |
|
| Coordinated Strategy for a Model-Based Decision Support Tool for Coronavirus Disease, Utah, USA | Emerging infectious diseases | | | 2021 | 3 | 15 |
|
| Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021 | Morbidity and mortality weekly report | | | 2021 | 4 | 22 |
|
| Maximizing and evaluating the impact of test-trace-isolate programs : A modeling study | PLoS medicine | | | 2021 | 3 | 4 |
|
| Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States | Nature communications | | | 2021 | 6 | 24 |
|
| A scenario modeling pipeline for COVID-19 emergency planning | Scientific reports | | | 2021 | 5 | 42 |
|
| HIT-COVID, a global database tracking public health interventions to COVID-19 | Scientific data | | | 2020 | 4 | 19 |
|
| The engines of SARS-CoV-2 spread | Science | | | 2020 | 2 | 33 |
|
| The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa : A modeling study | PLoS medicine | | | 2019 | 3 | 34 |
|
| Deploying digital health data to optimize influenza surveillance at national and local scales | PLOS computational biology | | | 2018 | 4 | 3 |
|
| Model distinguishability and inference robustness in mechanisms of cholera transmission and loss of immunity | Journal of theoretical biology | | | 2017 | 5 | 2 |
|
| Detecting signals of seasonal influenza severity through age dynamics | BMC infectious diseases | | | 2015 | 10 | 26 |
|
